Global Medical Sharps Market to Reach $45.3B by 2036, Driven by Safety Regulations

Rapid expansion projected as healthcare providers prioritize needlestick injury prevention and regulatory compliance

Apr. 3, 2026 at 11:05am

Got story updates? Submit your updates here. ›

An abstract illustration featuring a medical syringe defined by bright, neon-like lines against a dark background, conveying the concept of advanced, safety-focused healthcare technology.Glowing neon outlines of medical sharps symbolize the growing emphasis on safety and compliance in the healthcare industry.Newark Today

The global medical sharps market is poised for rapid expansion, projected to grow from $10.9 billion in 2026 to $45.3 billion by 2036, registering a robust CAGR of 15.3% over the forecast period. Growth is being driven by rising injection volumes, expanding vaccination programs, and stringent enforcement of occupational safety regulations across healthcare systems.

Why it matters

The medical sharps market is gaining momentum as regulatory bodies enforce strict safety protocols to minimize occupational hazards. Hospitals and clinics are increasingly adopting advanced sharps with built-in safety features to reduce injury risks and ensure compliance with global standards. At the same time, procurement decisions are shifting toward total cost of ownership, with buyers evaluating products based on safety performance, ease of use, and disposal efficiency.

The details

The market is witnessing a strong shift toward safety-engineered sharps, including retractable needles and shielded lancets, as healthcare providers prioritize needlestick injury prevention and regulatory compliance. Increasing prevalence of chronic diseases such as diabetes and cancer is further accelerating demand for injectable therapies, reinforcing the essential role of sharps in modern clinical care.

  • The global medical sharps market is projected to grow from $10.9 billion in 2026 to $45.3 billion by 2036.
  • The market is expected to register a CAGR of 15.3% over the forecast period from 2026 to 2036.

The players

BD (Becton Dickinson)

A leading player in the medical sharps market, focusing on safety innovation, ergonomic design, and regulatory compliance.

Terumo Corporation

A major competitor in the medical sharps market, investing in advanced safety mechanisms, scalable manufacturing, and integrated solutions.

B. Braun Melsungen

A prominent player in the medical sharps market, known for its focus on safety-engineered devices and compliance-driven value propositions.

Nipro Corporation

A key player in the medical sharps market, offering a range of safety-engineered sharps solutions for healthcare providers.

Smiths Medical

A leading supplier of medical sharps, providing a portfolio of safety-focused products and integrated waste management solutions.

Got photos? Submit your photos here. ›

What’s next

As healthcare systems evolve and injection-based therapies continue to rise, the medical sharps market offers significant opportunities for innovation, compliance-driven growth, and long-term value creation.

The takeaway

The global medical sharps market is poised for rapid expansion, driven by rising injection volumes, expanding vaccination programs, and stringent enforcement of occupational safety regulations. Healthcare providers are increasingly prioritizing safety-engineered sharps to reduce injury risks and ensure regulatory compliance, creating a strong demand for advanced solutions that address the total cost of ownership.